TMSB4X

Overview

TMSB4X is one of a number of genes affected by aberrant somatic hypermutation in B-cell lymphomas, which complicates the interpretation of mutations at this locus.

Relevance tier by entity

Entity Tier Description
BL 2-a aSHM target; Although recurrent, the relevance of mutations in BL is tenuous
DLBCL 1-a aSHM target and high-confidence DLBCL gene
FL 1-a aSHM target and high-confidence FL gene

Mutation incidence in large patient cohorts (GAMBL reanalysis)

Entity source frequency (%)
BL GAMBL genomes+capture 0.69
BL Thomas cohort 0.00
BL Panea cohort 2.00
DLBCL GAMBL genomes 12.43
DLBCL Schmitz cohort 20.85
DLBCL Reddy cohort 13.11
DLBCL Chapuy cohort 18.38
FL GAMBL genomes 4.39

Mutation pattern and selective pressure estimates

Entity aSHM Significant selection dN/dS (missense) dN/dS (nonsense)
BL Yes No 0.000 0.000
DLBCL Yes Yes 23.522 254.537
FL Yes Yes 60.545 310.498

aSHM regions

chr_name hg19_start hg19_end region regulatory_comment
chrX 12993308 12994511 intron active_promoter

[!NOTE] First described in DLBCL in 2017 by Albuquerque MA

View coding variants in ProteinPaint hg19 or hg38

image

View all variants in GenomePaint hg19 or hg38

image